Course: Ph. D. Programmes
Institute / University: National Institute For Research In Reproductive Health (NIRRH)
The institute began its journey as a family planning unit in 1954 at the ICRC (Later named as Cancer Research Unit). In 1956, the unit was reorganized as the Contraceptive Testing Unit (CTU). Within 5 years of its inception, the Institute broadened the spectrum of its activities and was therefore renamed as Reproductive Physiology Unit (RPU). During 1956-62, the unit was shifted thrice to accommodate its need for more space. This was paralleled by enormous expansion of its research activities.
In 1977, the Government of India recognized the need to review its national programs on population stabilization and welfare of the families. This assessment resulted in a major paradigm shift. The focus was shifted from “family planning” to “family welfare”. This was followed by the landmark development in 1994 when India as a signatory to the ‘International Conference on Population and Development’ declaration re-oriented the Family Welfare program to Reproductive and Child Health (RCH) program. This shift was more apparent in the beginning of the 21st century when the institute decided to adopt more holistic approach towards reproductive health. The institute ventured into several new areas of direct relevance to national needs. On 20th July 2002, the institute was rechristened as ‘National Institute for Research in Reproductive Health’. The national status was accorded to the Institute in recognition of its scientific contributions made since its inception.
Ph. D. in Reproductive Health
National Center for Preclinical Reproductive and Genetic Toxicology was jointly established (Year) at the institute by the Department of Science and Technology (DST) and Indian Council of Medical Research (ICMR). The center is one among the few centers in the country that undertakes comprehensive research and testing of new molecules for pre-clinical reproductive and genetic toxicity. The center has been providing services in the area of reproductive and genetic toxicology to various academic institution and pharma industries by following the Organisation for Economic Co-operation and Development (OECD) guidelines and good laboratory practices (GLP). The facility undertakes safety as well as efficacy testing of various molecules.
For more details visit here.